![Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrclinonc.2013.46/MediaObjects/41571_2013_Article_BFnrclinonc201346_Fig1_HTML.jpg)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
![Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001073/F4.large.jpg)
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
![A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9c3e4a4c-083a-437a-95cf-ca2f05cd169b/eji3979-gra-0001-m.png)
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig1_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal](https://www.embopress.org/cms/asset/a1702c60-fae3-4415-b29e-2cdb3c6cb66b/embj201797980-abs-0001-m.jpg)
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal
![Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model](https://www.frontiersin.org/files/Articles/478945/fimmu-10-02680-HTML/image_m/fimmu-10-02680-g001.jpg)
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
![Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells](https://pub.mdpi-res.com/cancers/cancers-12-02612/article_deploy/html/images/cancers-12-02612-g001.png?1602081308)
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig2_HTML.jpg)